🟢 Alvotech is trading 11% up today after FDA approval doubled SIMLANDI manufacturing capacity

Alvotech is trading at ISK 754, up +10.56%, after FDA approval allowed a second Reykjavik suite to make SIMLANDI drug substance for U.S. supply.

• On October 5, 2026, the company said the approval effectively doubles available manufacturing capacity and confirms resolution of inspection-related matters at the site.
• Volume data was not provided.